Drug Pipeline

TCD601 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
3
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT04803058 A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE) Kidney Transplantation Active, Not Recruiting
NCT07508787 A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept… Renal Transplant Failure and Rejection Not Yet Recruiting
Phase 1
NCT06453668 A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis… ALS Recruiting
Early Phase 1
NCT06326476 Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of… Hidradenitis Suppurativa Recruiting
Sponsors Running TCD601 Trials
Disease Areas
Get alerts when TCD601 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free